(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HUB ORGANOID

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

HUB ORGANOID

ST13

US500000079276822

Classe

1, 5, 42, 44

Pedido

79276822

Registro

6253487

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

40

Atualização mais recente

27/01/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 44

Data de depósito

23/10/2019

Data de registro

26/01/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

26/01/2021

Última transação

27/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

78

Localização do titular

NL

Examinador

KAPLAN, VALERIE ELIZABETH

Unidade examinadora

L70

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

HUB Organoids IP B.V.
HUB Organoids B.V. IP
S. T. (pessoa física)

Representantes

William C. Wright Epstein Drangel LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Cellsstem cellsepithelial cellsall for scientific research purposes; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell culturesfor scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes

Classe 5

Cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; stem cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; stem cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; epithelial cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; epithelial cells for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinarydiagnostic and therapeutic purposesfor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; cell cultures for medical and veterinarydiagnostic and therapeutic purposescells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cell cultures for medical and veterinarydiagnostic and therapeutic purposescells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cellscultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx; cellsepithelial cellsorganoids and cell cultures for personalised medicinefor diagnosis and treatment of diseases or disorders of epithelial tissue in the sensoryreproductiveurinarydigestivecirculatoryendocrinenervouslymphaticintegumentaryrespiratory systems; cellsepithelial cellsorganoids and cell cultures for personalised medicinefor diagnosis and treatment of diseases of epithelial tissue in the liverpancreasintestinestomachprostatelungbreastkidneyovarianuterusfallopian tubesweat glandhair follicleskinoesophagusthyroidnosethroatsinustracheaoral cavitysalivary glandlarynx or pharynx

Classe 42

Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compounddrug and vaccine discoverydevelopment servicescharacterization and validation services in the nature of product quality and efficacy testing for medical compoundsdrugs and vaccines; candidate drug and vaccinedrug and vaccine testing servicestesting of pharmaceuticals; companion diagnosticsthe scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoidsself-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine

Classe 44

Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services

Publicações

Histórico de despachos e eventos da marca no USPTO.

40 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

26/01/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/10/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

28/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

28/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

28/10/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/05/2024

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/04/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

23/05/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

29/04/2021

FIMP

FINAL DISPOSITION PROCESSED

29/04/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

26/04/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

26/01/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/11/2020

PUBO

PUBLISHED FOR OPPOSITION

10/11/2020

GPNX

NOTIFICATION PROCESSED BY IB

08/11/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

21/10/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

21/10/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

21/10/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/10/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/08/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

25/08/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

24/08/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

24/08/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

24/08/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

24/08/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

24/08/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

24/08/2020

RFNT

REFUSAL PROCESSED BY IB

21/03/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

20/03/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

26/02/2020

RFRR

REFUSAL PROCESSED BY MPU

26/02/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/02/2020

CNRT

NON-FINAL ACTION WRITTEN

04/02/2020

MAFR

APPLICATION FILING RECEIPT MAILED

31/01/2020

DOCK

ASSIGNED TO EXAMINER

28/01/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

27/01/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

23/01/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HUB ORGANOID ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.